Reuters Business
@ReutersBiz
The latest business and financial news from around the 🌍 with insights from @breakingviews.
Our new daily podcast is here:
加入 June 2008
237 正在關注 3.4M 粉絲
Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and nutritional science to develop products aimed at millions of consumers taking medicines such as Ozempic and Wegovy
顯示更多
